These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3944711)

  • 21. [Our experience with the prevention of hepatitis B].
    Frolov AF; Orgel' MIa; Mel'nichenko TIu; Martsinkovskiĭ LT; Iakushev VG
    Gematol Transfuziol; 1987 Sep; 32(9):46-8. PubMed ID: 3692128
    [No Abstract]   [Full Text] [Related]  

  • 22. Comments on the role of epidemiology in the investigation of hepatitis B virus.
    London WT; Blumberg BS
    Epidemiol Rev; 1985; 7():59-79. PubMed ID: 2996918
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection.
    Bernier RH; Sampliner R; Gerety R; Tabor E; Hamilton F; Nathanson N
    Am J Epidemiol; 1982 Aug; 116(2):199-211. PubMed ID: 7114032
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic viral hepatitis in thalassemic liver disease. A long-term study in patients with acute hepatitis with nontransfusion-dependent thalassemia minor.
    Pastore G; Tannoia N; Angarano G; Monno L; Santantonio T; Pietrapertosa A; Malcangi G; Putignano A; Schiraldi O
    Vox Sang; 1983; 44(1):14-24. PubMed ID: 6402856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emerging pattern of post-transfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Am J Med Sci; 1975; 270(2):329-34. PubMed ID: 1235474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of post-transfusion hepatitis.
    Conrad ME
    Am J Hematol; 1976; 1(3):357-65. PubMed ID: 63244
    [No Abstract]   [Full Text] [Related]  

  • 27. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India.
    Makroo RN; Arora JS; Chowdhry M; Bhatia A; Thakur UK; Minimol A
    Indian J Pathol Microbiol; 2013; 56(4):378-83. PubMed ID: 24441225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.
    De Virgiliis S; Fiorelli G; Fargion S; Cornacchia G; Sanna G; Cossu P; Murgia V; Cao A
    J Clin Pathol; 1980 Oct; 33(10):949-53. PubMed ID: 7430360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of hepatitis B and C prevalence and liver function in multiply transfused thalassemic and their parents.
    Williams TN; Wonke B; Donohue SM
    Indian Pediatr; 1992 Sep; 29(9):1119-24. PubMed ID: 1452308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unscreened transfusion related human immunodeficiency virus type-I infection amongst Indian thalassemic children.
    Kumar RM; Rizk DE; Khuranna AK
    Am J Hematol; 1996 Sep; 53(1):51-2. PubMed ID: 8813103
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment and prevention of hepatitis B and C in thalassemia.
    Mallat ME; Sharara AI
    Hemoglobin; 2009; 33 Suppl 1():S139-44. PubMed ID: 20001618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed hemolytic transfusion reaction in a thalassemic child.
    Kashyap R; Choudhry VP
    Indian J Pediatr; 1994; 61(6):726-8. PubMed ID: 7721381
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunoradiometric analysis and the prevention of posttransfusion hepatitis B].
    Leĭbenzon AS; Malakhova TS; Anan'ev VA; Viazov SO; Shchegolev AS
    Vopr Virusol; 1988; 33(3):292-4. PubMed ID: 3176430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttransfusion hepatitis B.
    Hoofnagle JH
    Transfusion; 1990 Jun; 30(5):384-6. PubMed ID: 2360228
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is blood containing anti-HBe safe for transfusion?
    Chiba S; Fujiwara T; Nakao T; Ito H
    J Pediatr; 1977 Oct; 91(4):684. PubMed ID: 909000
    [No Abstract]   [Full Text] [Related]  

  • 37. Posttransfusion hepatitis: epidemiology, experimental studies and US perspective.
    Barker LF
    Bibl Haematol; 1980; (46):3-14. PubMed ID: 6246872
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for hepatitis B virus markers is not justified in West African transfusion centres.
    Ryder RW; Whittle HC; Wojiecowsky T; Moffat WM; Baker BA; Sarr E; Oldfield F
    Lancet; 1984 Aug; 2(8400):449-52. PubMed ID: 6147513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmission of hepatitis B by an oral surgeon.
    Reingold AL; Kane MA; Murphy BL; Checko P; Francis DP; Maynard JE
    J Infect Dis; 1982 Feb; 145(2):262-8. PubMed ID: 7054329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On transmission of hepatitis by blood transfusion (author's transl)].
    Fiser-Herman M; Mihaljević I
    Lijec Vjesn; 1981; 103(2-3):108-9. PubMed ID: 7311694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.